Stocktwits on MSN
Lupin Gains On FDA Nod For HIV Drug; Technicals Suggest Potential Upside Above ₹2,060
Lupin shares climbed on Thursday after the U.S. Food and Drug Administration gave a tentative approval to the company to sell ...
Lupin's subsidiary, Nanomi BV, is set to acquire VISUfarma BV for 190 million euros, aiming to enhance its European market presence. The acquisition will broaden Lupin's specialty franchise in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback